The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study
Open accessThe DOI matches its Crossref record; 39 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Available iron chelation regimes in thalassaemia may achieve different changes in cardiac and hepatic iron as assessed by MR. The aim of this study was to assess the efficacy of four available iron chelator regimes in 232 thalassaemia major patients by assessing the rate of change in repeated measurements of cardiac and hepatic MR. RESULTS: For the heart, deferiprone and the combination of deferiprone and deferoxamine significantly reduced cardiac iron at all levels of iron loading. As patients were on deferasirox for a shorter time, a second analysis ("Initial interval analysis") assessing the change between the first two recorded MR results for both cardiac and hepatic iron (minimum interval 12 months) was made. Combination therapy achieved the most rapid fall in cardiac iron load at all levels and deferiprone alone was significantly effective with moderate and mild iron load. In the liver, deferasirox effected significant falls in iron load and combination therapy resulted in the most rapid decline. CONCLUSION: With the knowledge of the efficacy of the different available regimes and the specific iron load in the heart and the liver, appropriate tailoring of chelation therapy should allow clearance of iron. Combination therapy is best in reducing both cardiac and hepatic iron, while monotherapy with deferiprone or deferasirox are effective in the heart and liver respectively. The outcomes of this study may be useful to physicians as to the chelation they should prescribe according to the levels of iron load found in the heart and liver by MR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a number of (pharmacological drug) approved iron chelators do exist and thus clearly have the potential to prove beneficial in treating diseases and the sequelae of toxin exposure whose aetiology involves poorly liganded iron via the Fenton reaction”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload
Anderson, L. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2822 · Cited by 1,682
Borgna‐Pignatti, C., Rugolotto, S., Stefano, P. D., Zhao, H., Cappellini, M. D., Vecchio, G. C. D., Romeo, M. A., Forni, G. L., Gamberini, M. R., Ghilardi, R., et al. (2004) · PubMed · Cited by 1,119
Wood, J. C., Enriquez, C., Ghugre, N., Tyzka, J. M., Carson, S., Nelson, M. D., & Coates, T. D. (2005) · Blood · doi:10.1182/blood-2004-10-3982 · Cited by 1,045
Cappellini, M. D. (2006) · Blood · doi:10.1182/blood-2005-08-3430 · Cited by 717
Hepatic Iron Concentration and Total Body Iron Stores in Thalassemia Major
Angelucci, E., Brittenham, G. M., McLaren, C. E., Ripalti, M., Baronciani, D., Giardini, C., Galimberti, M., Polchi, P., & Lucarelli, G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008033430503 · Cited by 607
Modell, B., Khan, M., Darlison, M., Westwood, M. A., Ingram, D., & Pennell, D. J. (2008) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-10-42 · Cited by 600
Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia Register
Modell, B., Khan, M., & Darlison, M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02357-6 · Cited by 583
Pennell, D. J. (2006) · Blood · doi:10.1182/blood-2005-07-2948 · Cited by 495
Tanner, M. A., Galanello, R., Dessi, C., Smith, G. C., Westwood, M. A., Agus, A., Roughton, M., Assomull, R., Nair, S. V., Walker, J. M., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.648790 · Cited by 482
Anderson, L. J., Westwood, M. A., Holden, S., Davis, B., Prescott, E., Wonke, B., Porter, J. B., Malcolm Walker, J., & Pennell, D. J. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05202.x · Cited by 414
Research works printed but not linked: 3
- Eleftheriou, 2006, Response of myocardial T2* to oral deferasirox monotherapy for 1 year in 29 patients with transfusion-dependent anaemias; A subgroup analysis, Haematologica, 91, abst 999
- Pepe, 2008, Comparison of deferasirox, deferiprone and desferrioxamine effectiveness on myocardial iron concenrations and biventricular function by quantitative MRI in thalassemia major, ASH Annual Meeting, San Francisco, USA, 6–9 December
- Grady, 2000, Optimising chelation therapy: Combining deferiprone and deferoxamine, Blood, 96, 604
Cited by
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
Iron Overload Cardiomyopathy in Clinical Practice
Kremastinos, D. T., & Farmakis, D. (2011) · Circulation · doi:10.1161/circulationaha.111.050773 · Cited by 355
Practical medical applications of quantitative MR relaxometry
Margaret Cheng, H., Stikov, N., Ghugre, N. R., & Wright, G. A. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23718 · Cited by 238
An update on iron chelation therapy.
(2012) · Europe PMC (PubMed Central) · doi:10.2450/2012.0008-12 · Cited by 233
β-Thalassemia Cardiomyopathy: History, Present Considerations, and Future Perspectives
Kremastinos, D. T., Farmakis, D., Aessopos, A., Hahalis, G., Hamodraka, E., Tsiapras, D., & Keren, A. (2010) · Circulation: Heart Failure · doi:10.1161/circheartfailure.109.913863 · Cited by 209
Metadata
- Authors
- Berdoukas, V., Chouliaras, G., Moraitis, P., Zannikos, K., Berdoussi, E., & Ladis, V.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- Corresponding author
- Berdoukas, Vasilios
- ORCID
- Chouliaras, Giorgos
- Venue
- Journal of Cardiovascular Magnetic Resonance
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 11
- Issue
- 1
- Pages
- 20
- ISSN
- 1097-6647 (ISSN-L)
- PMC
- PMC2713224
- OpenAlex
- W2107631387
- Cited by
- 87
- References
- 41
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 2 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 4 · 2017: 7 · 2016: 6 · 2015: 4 · 2014: 7 · 2013: 4 · 2012: 7
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/2.0/ (vor, 178 d)
- Locations
- Journal of Cardiovascular Magnetic Resonance (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- thalassemia major, iron chelation therapy, cardiac iron, hepatic iron, deferiprone, deferoxamine, deferasirox, iron overload, MRI iron quantification
- MeSH terms
- Deferiprone, Adult, Deferoxamine, Drug Therapy, Combination, Female, Humans, Iron, Iron Chelating Agents, Liver, Magnetic Resonance Imaging, Male, Myocardium, Pyridones, Retrospective Studies, Severity of Illness Index, Time Factors, Logistic Models, Treatment Outcome, beta-Thalassemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study. https://app.cochat.ai/papers/10.1186/1532-429x-11-20
- The paper
- Berdoukas, V., Chouliaras, G., Moraitis, P., Zannikos, K., Berdoussi, E., & Ladis, V. (2009). The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study. Journal of Cardiovascular Magnetic Resonance. https://doi.org/10.1186/1532-429x-11-20
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.